Bpreven

Company Overview

Snapshot

Founded in January 2023 by Inon Ivgi, Bpreven operates with 11–50 employees. The company has raised $550,000 across three funding rounds. In December 2025, Bpreven announced a breakthrough initiative from Sderot, focusing on advanced mental health technologies.

Business overview

Bpreven develops an advanced AI-powered EHR platform specifically for mental health services, integrating innovative algorithms, clinical decision-support tools, and structured therapeutic workflows. The platform enhances assessment, treatment planning, and ongoing care management by providing data-driven insights and evidence-based clinical intervention models. Serving the United States, Israel, and Europe, Bpreven aims to improve efficiency for clinicians, expand accessibility to emotional support, and strengthen psychological resilience, operating within the Health Tech & Life Sciences sector, with a focus on Digital Therapeutics and Artificial Intelligence.

Strategic signal

In December 2025, Bpreven announced a breakthrough initiative from Sderot, focusing on the application of advanced technologies in mental health. This signals the company's commitment to leveraging AI and innovative solutions to address critical needs in mental healthcare, potentially expanding its reach and impact in underserved communities and demonstrating a strong forward trajectory in technology-driven mental wellness.

Company Intelligence Q&A

When was Bpreven founded and by whom?

Bpreven was founded in January 2023 by Inon Ivgi.

What is Bpreven's primary focus in the healthcare sector?

Bpreven focuses on developing an AI-powered EHR platform specifically for mental health services, aiming to enhance assessment, treatment planning, and ongoing care management.

What significant initiative did Bpreven announce in December 2025?

In December 2025, Bpreven announced a breakthrough initiative from Sderot, focusing on the application of advanced technologies in mental health.

How much capital has Bpreven raised to date?

Bpreven has raised a total of $550,000 across three funding rounds.

What is Bpreven's product stage?

Bpreven's product is currently in the R&D stage, as indicated by the company's product stage data.